Other innovative projects in our group are:
- to identify, validate and propagate in the imaging and medical communities new protocols for improved skeletal muscle characterization. Research areas will be: multiple quantum (zero and double quantum) imaging of water interaction with macromolecules, activatable CEST and PARACEST contrast agent imaging aiming at unambiguous identification of labelled cells in diseased muscle, optimisation of muscle functional imaging based on arterial spin labelling (ASL) and blood-level dependent (BOLD) contrast, definition of metabolic indices of muscle viability based on advanced spectroscopy imaging (phosphocreatine, creatine, lactate)…
- to develop tools and protocols for the monitoring of cell and gene therapies applied to skeletal muscle. A key step is to define the most adequate labelling strategies (cells, viral particles, liposomes, plasmids). This work will be performed in close collaboration with laboratories highly specialized in contrast agent synthesis and bio-target labelling.